Skalska, L.* ; Begley, V.* ; Beltran, M.* ; Lukauskas, S. ; Khandelwal, G.* ; Faull, P.* ; Bhamra, A.* ; Tavares, M.* ; Wellman, R.* ; Tvardovskiy, A. ; Foster, B. ; Ruiz de Los Mozos, I.* ; Herrero, J.* ; Surinova, S.* ; Snijders, A.P.* ; Bartke, T. ; Jenner, R.G.*
Nascent RNA antagonizes the interaction of a set of regulatory proteins with chromatin.
Mol. Cell 81, 2944-2959.e10 (2021)
A number of regulatory factors are recruited to chromatin by specialized RNAs. Whether RNA has a more general role in regulating the interaction of proteins with chromatin has not been determined. We used proteomics methods to measure the global impact of nascent RNA on chromatin in embryonic stem cells. Surprisingly, we found that nascent RNA primarily antagonized the interaction of chromatin modifiers and transcriptional regulators with chromatin. Transcriptional inhibition and RNA degradation induced recruitment of a set of transcriptional regulators, chromatin modifiers, nucleosome remodelers, and regulators of higher-order structure. RNA directly bound to factors, including BAF, NuRD, EHMT1, and INO80 and inhibited their interaction with nucleosomes. The transcriptional elongation factor P-TEFb directly bound pre-mRNA, and its recruitment to chromatin upon Pol II inhibition was regulated by the 7SK ribonucleoprotein complex. We postulate that by antagonizing the interaction of regulatory proteins with chromatin, nascent RNA links transcriptional output with chromatin composition.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Rna Polymerase Ii ; Rnase ; Chromatin ; Histone Modification ; Nascent Rna ; Nucleosome ; Nucleosome Remodeller ; Pre-mrna ; Transcription Factor ; Transcriptional Elongation; Repressive Complex 2; Polymerase-ii; P-tefb; Pervasive Transcription; Binding Protein; Snrnp Complex; Web Server; 7sk Snrnp; Hiv-1 Tat; Gene
Keywords plus
Language
english
Publication Year
2021
Prepublished in Year
HGF-reported in Year
2021
ISSN (print) / ISBN
1097-2765
e-ISSN
1097-4164
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 81,
Issue: 14,
Pages: 2944-2959.e10
Article Number: ,
Supplement: ,
Series
Publisher
Elsevier
Publishing Place
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502800-001
Grants
Helmholtz Society
ERC
Worldwide Cancer Research
Blood Cancer UK
European Research Council (ERC)
Cancer Research UK Cancer Immunotherapy Network Accelerator (CITA)
Proteomics Research TTP - Cancer Research UK-UCL Centre
UCL Bill Lyons Informatics Centre - Cancer Research UK-UCL Centre
UCL Cancer Institute Genomics TTP
Copyright
Erfassungsdatum
2021-07-22